We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

467 hedge funds and large institutions have $5.28B invested in Bioverativ Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $14.1M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
11.62%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$21.4M
Puts
$14.1M
Net Calls
+$7.29M
Net Calls Change
+$7.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$433M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$429M
3
VH
ValueAct Holdings
California
+$418M
4
Primecap Management
Primecap Management
California
+$381M
5
HM
HealthCor Management
New York
+$246M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TDC
426
Thompson Davis & Co
Virginia
$2K +$1.43K +29 New
AW
427
Alpha Windward
Massachusetts
$2K +$1.53K +31 New
BIG
428
Bellwether Investment Group
Tennessee
$2K +$1.53K +31 New
AF
429
Arrow Financial
New York
$2K +$1.58K +32 New
CCM
430
Cribstone Capital Management
Maine
$2K +$1.58K +32 New
VNA
431
Valley National Advisers
Pennsylvania
$2K +$1.77K +36 New
BWA
432
Burt Wealth Advisors
Maryland
$2K +$1.82K +37 New
PCFFS
433
Pacific Center for Financial Services
California
$2K +$1.87K +38 New
AC
434
Alexandria Capital
Virginia
$2K +$2.02K +41 New
Manulife (Manufacturers Life Insurance)
435
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K +$2.17K +44 New
HI
436
Hudock Inc
Pennsylvania
$2K +$2.46K +50 New
HCC
437
Hirtle Callaghan & Co
Pennsylvania
$2K +$2.66K +54 New
Walleye Trading
438
Walleye Trading
New York
$1.33K +$1.2M +24,440 New
TFA
439
Transamerica Financial Advisors
Florida
$1K +$99 +2 New
WAMC
440
Western Asset Management Company
California
$1K +$99 +2 New
GAM
441
Guinness Asset Management
United Kingdom
$1K +$493 +10 New
AA
442
Apriem Advisors
California
$1K +$591 +12 New
MCM
443
MV Capital Management
Maryland
$1K +$739 +15 New
GRP
444
Global Retirement Partners
California
$1K +$788 +16 New
AF
445
Allworth Financial
California
$1K +$837 +17 New
BC
446
Bartlett & Co
Ohio
$1K +$837 +17 New
KKAMG
447
Kernodle & Katon Asset Management Group
Arkansas
$1K +$887 +18 New
ANBT
448
American National Bank & Trust
Texas
$1K +$936 +19 New
PVH
449
Psagot Value Holdings
Israel
$1K +$985 +20 New
ST
450
Smithfield Trust
Pennsylvania
$1K +$985 +20 New
15 16 17
18
19

BIVV Hedge Fund Activity: Q1 2017 in Review

467 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2017, worth a combined $5.28B.

Buyers outnumbered sellers: 467 funds opened new BIVV positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $433M.

  • 467 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $5.28B of Bioverativ Inc. Common Stock stock for Q1 2017.
  • 467 funds opened new Bioverativ Inc. Common Stock positions in Q1 2017 and 0 closed out, a net change of +467 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $433M added.

Based on aggregated 13F filings for Q1 2017.